Hormone-refractory and metastatic prostate cancer - Palliative radiotherapy

Frontiers of Radiation Therapy and Oncology

Volumn 41, Issue , 2008, Pages 117-125

  Moser, L ^a   Schubert, T ^a   Hinkelbein, W ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN;

CONFERENCE PAPER; DRUG RESISTANCE; HUMAN; MALE; METASTASIS; METHODOLOGY; PALLIATIVE THERAPY; PATHOLOGY; PROSTATE TUMOR;

ANDROGEN ANTAGONISTS; DRUG RESISTANCE, NEOPLASM; HUMANS; MALE; NEOPLASM METASTASIS; PALLIATIVE CARE; PROSTATIC NEOPLASMS;

EID: 49449091414     PISSN: 00719676     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000139886     Document Type: Conference Paper

References (26)

1. Bates T, Yarnold JR, Blitzer P, Nelson OS, Rubin P, Maher EJ: Bone metastases consensus statement. Int J Radiat Oncol Biol Phys 1992;23:215-216.
2. Gaze MN, Kelly CG, Kerr GR, Cull A, Cowie VJ, Gregor A, Howard GC, Rodger A: Pain relief and quality of life following radiotherapy for bone metastases: a randomized trial of two fractionation schedules. Radiother Oncol 1997;45:109-116.
3. Hartsell WF, Scott CB, Bruner DW, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach M, Suh JH, Demas WF, Movsas B, Petersen IA, Konski AA, Cleeland CS, Janjan NA, DeSilvio M: Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 2005;97:798-804.
4. Jeremic B, Shibamoto Y, Acimovic L, Milicic B, Milisavljevic S, Nikolic N, Aleksandrovic J, Igrutinovic I: A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. Int J Radiat Oncol Biol Phys 1998;42:161-167.
5. Koswig S, Budach V: Remineralization and pain relief in bone metastases after different radiotherapy fractions (10 x 3 vs. 1 x 8 Gy): a prospective study. Strahlenther Onkol 1999;175:500-508.
6. Nielsen OS, Bentzen SM, Sandberg E, Gadeberg CC, Timothy AR: Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol 1998;47:233-240.
7. Niewald M, Tkocz HJ, Abel U, Scheib T, Walter K, Nieder C, Schnabel K, Berberich W, Kubale R, Fuchs M: Rapid course radiation therapy vs. more standard treatment: a randomized trial for bone metastases. Int J Radiat Oncol Biol Phys 1996;36:1085-1089.
8. Rasmusson B, Vejborg I, Jensen AB, Andersson M, Banning AM, Hoffmann T, Pfeiffer P, Nielsen HK, Sjogren P: Irradiation of bone metastases in breast cancer patients: a randomized study with 1 year follow-up. Radiat Oncol 1995;34:179-184.
9. Steenland E, Leer JW, van Houwelingen H, Post WJ, van den Hout WB, Kievit J, de Haes H, Martijn H, Oei B, Vonk E, van der Steen-Banasik E, Wiggenraad RG, Hoogenhout J, Warlam-Rodenhuis C, van Tienhoven G, Wanders R, Pomp J, van Reijn M, van Mierlo I, Rutten E: The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 1999;52:101-109.
10. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party. Radiother Oncol 1999;52:111-121.
11. Falkmer U, Järhult J, Wersäll P, Cavallin-Stahl E: A systematic overview of radiation therapy effects in skeletal metastases. Act Oncol 2003;42:620-633.
12. Quilty PM, Kirk D, Bolger JJ, Dearnaley DP, Lewington VJ, Mason MD, Reed NS, Russell JM, Yardley J: A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer. Radiother Oncol 1994;31:33-40.
13. Bach F, Larsen BH, Rohde K, Borgesen SE, Gjerris F, Boge-Rasmussen T, Agerlin N, Rasmusson B, Stjernholm P, Sorensen PS: Metastatic spinal cord compression: occurrence, symptoms, clinical presentations and prognosis in 398 patients with spinal cord compression. Acta Neurochir 1990;107:37-43.
14. Rades D, Stalpers LJA, Veninga T, Schulte R, Hoskin PJ, Obralic N, Bajrovic A, Rudat V, Schwarz R, Hulshof MC, Poortmans P, Schild SE: Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. J Clin Oncol 2005;23:3366-3375.
15. Rades D, Fehlauer F, Schulte R, Veninga T, Stalpers LJA, Basic H, Bajrovic A, Hoskin PJ, Tribius S, Wildfang I, Rudat V, Engenhart-Cabilic R, Karstens JH, Alberti W, Dunst J, Schild SE: Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol 2006;24:3388-3393.
16. Rades D, Stalpers LJ, Veninga T, Rudat V, Schulte R, Hoskin PJ: Evaluation of functional outcome and local control after radiotherapy for metastatic spinal cord compression in patients with prostate cancer. J Urol 2006;175:552-556.
17. Townsend PW, Rosenthal HG, Smalley SR, Cozad SC, Hassanein RE: Impact of postoperative radiation therapy and other perioperative factors on outcome after orthopedic stabilization of impending or pathologic fractures due to metastatic disease. J Clin Oncol 1994;12:2345-2350.
18. Schulte M, Hartwig E, Sarkar M, Arand M: Endoprostetic treatment of metastatic pathological fractures. Anticancer Res 1998;18:2251-2252.
19. Perez CA, Cosmatos D, Garcia DM, Eisbruch A, Poulter CA: Irradiation in relapsing carcinoma of the prostate. Cancer 1993;71(suppl):1110-1122.
20. Ampil FL: Radiation therapy palliation in malignancy-associated ureteral obstruction. Radiat Med 1989;7:282-286.
21. Kawakami S, Kawai T, Yamauchi T, Yonese J, Ueda T, Ishibashi K: Palliative radiotherapy for bone pain in hormone refractory prostate cancer. Nippon Hinyokika Gakkai Zasshi 1993;84:1681-1684.
22. Furuya Y, Akakura K, Akimoto S, Ichikawa T, Ito H: Radiotherapy for local progression in patients with hormone-refractory prostate cancer. Int J Urol 1999;6:187-191.
23. Livsey JE, Cowan RA, Wylie JP, Swindell R, Read G, Khoo VS, Logue JP: Hypofractionated conformal radiotherapy in carcinoma of the prostate: five-year outcome analysis. Int J Radiat Oncol Biol Phys 2003;57:1254-1257.
24. Akimoto T, Muramatsu H, Takahashi M, Saito J, Kitamoto Y, Harashima K, Miyazawa Y, Yamada M, Ito K, Kurokawa K, Yamanaka H, Nakano T, Mitsuhashi N, Niibe H: Rectal bleeding after hypofractionated radiotherapy for prostate cancer: correlation between clinical and dosimetric parameters and incidence of grade 2 or worse rectal bleeding. Int J Radiat Oncol Biol Phys 2004;60:1033-1039.
25. Lukka H, Hayter C, Julian JA, Warde P, Morris WJ, Gospodarowicz M, Levine M, Sathya J, Choo R, Prichard H, Brundage M, Kwan W: Randomized trial comparing two fractionation schedules for patients with localized prostate cancer. J Clin Oncol 2005;23:6132-6138.
26. Kupelian PA, Thakkar VV, Khuntia D, Reddy CA, Klein EA, Mahadevan A: Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes. Int J Radiat Oncol Biol Phys 2005;63:1463-1468.